Adjunctive Ketamine Does Not Relieve Cancer Pain
December 5th 2012
Subcutaneous ketamine administered in conjunction with opioids and conventional adjuvant therapy does not lessen chronic uncontrolled cancer pain, according to the results of a phase III study. The regimen also produces a significant spike in toxicity.